Form 4: Global Medical REIT CEO and President Mark Decker Jr. Significantly Increases Stake with Over $1 Million in Stock Purchases and Equity Grant

Global Medical REIT Inc.'s CEO and President, Mark Okey Decker Jr., has demonstrated strong confidence in the company by acquiring 160,000 shares of common stock through open-market purchases and receiving a grant of 158,730 LTIP Units.

Summary

• Mark Okey Decker Jr., CEO and President of Global Medical REIT Inc. (GMRE), acquired a total of 160,000 shares of common stock through multiple open-market purchases.
• These purchases occurred on June 24, 2025, and June 25, 2025, at weighted average prices ranging from $6.31 to $6.615 per share.
• The total value of the common stock purchased by Mr. Decker Jr. is approximately $1,042,470.01.
• Following these transactions, Mr. Decker Jr. beneficially owns 160,000 shares of common stock directly.
• Additionally, Mr. Decker Jr. was granted 158,730 LTIP Units in Global Medical REIT L.P., the operating partnership of the Issuer, on June 23, 2025.
• These LTIP Units were granted under the Issuer's 2016 Equity Incentive Plan in connection with his appointment as President and Chief Executive Officer, effective June 23, 2025.
• The LTIP Units vest on the third anniversary of the grant date (June 23, 2028) and can be exchanged for cash or common stock on a one-for-one basis upon vesting and achieving capital account parity.

Sentiment

Score: 7

Explanation: The document indicates strong insider confidence through significant stock purchases by the CEO and President, aligning management interests with shareholders, which is generally viewed positively by the market.

Positives

• Significant open-market purchases by the CEO and President signal strong insider confidence in the company's current valuation and future prospects.
• The acquisition of 160,000 shares directly aligns management's financial interests with those of common shareholders.
• The grant of LTIP Units as part of executive compensation further incentivizes long-term performance and shareholder value creation.

Future Outlook

The LTIP Units granted to the CEO and President are scheduled to vest on the third anniversary of the grant date, June 23, 2028, at which point they can be exchanged for cash or common stock, aligning future executive incentives with long-term company performance.

Management Comments

• Management's actions, specifically the significant open-market purchases of common stock, signal strong confidence in the company's current valuation and future prospects.
• The grant of LTIP Units reflects the company's commitment to aligning executive compensation with long-term shareholder value creation.

Industry Context

This filing reflects typical executive compensation practices within the REIT sector, particularly for newly appointed senior leadership, combined with voluntary insider buying that often indicates a positive outlook on the company's specific medical real estate portfolio and market position.

Management Changes

Corporate Governance

Related Party Transactions

• Grant of 158,730 LTIP Units to Mark Okey Decker Jr., who is the CEO, President, and a Director of Global Medical REIT Inc., representing a form of executive compensation.

Stakeholder Impact

• Shareholders: Positive impact due to increased insider ownership, signaling management confidence and aligning interests.
• Employees: No direct impact mentioned in this filing.
• Customers/Suppliers/Creditors: No direct impact mentioned in this filing.

Next Steps

• Vesting of 158,730 LTIP Units on June 23, 2028, subject to the terms of the 2016 Equity Incentive Plan.

Key Dates

Keywords

Global Medical REIT, GMRE, Insider Trading, SEC Form 4, Stock Purchase, CEO, President, LTIP Units, Executive Compensation, Beneficial Ownership, Real Estate Investment Trust, Healthcare REIT